The Cell and Gene Therapy Catapult is requesting a cloud-based scientific literature content and management platform. The platform should provide all staff with efficient access to scholarly articles, research papers, and other relevant business, pharmaceutical and regulatory content. The contract will be for a one-year period, with the option to extend for two further one-year periods (1+1+1)